Drugs / Surface Antigen, Inactivated, (Adjuvanted with MF59C.1), form. 2006-07
Surface Antigen, Inactivated, (Adjuvanted with MF59C.1), form. 2006-07
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00329927 | Jun 2006 → ? | influenza | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Surface Antigen, Inactivated, (Adjuvanted with MF59C.1), form. 2006-07 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00329927 ↗ |
| Modality | Vaccine | “Influenza Vaccine” NCT00329927 ↗ |